Skip to main content
Eric Simpson, MD, Dermatology, Portland, OR, Portland HCS

EricLawrenceSimpsonMD

Dermatology Portland, OR

Associate Professor, Dermatology, Oregon Health and Science University School of Medicine

Dr. Simpson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Simpson's full profile

Already have an account?

Education & Training

  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Dermatology, 1999 - 2002
  • Baylor University Medical Center
    Baylor University Medical CenterInternship, Internal Medicine, 1998 - 1999
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1998

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2002 - 2025
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Baricitinib Combined with Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis  
    Lawrence F Eichenfield, Eric L Simpson, JAMA Dermatology
  • Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis  
    Jonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
  • Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families  
    Jonathan I Silverberg, Amy S Paller, Mark Boguniewicz, Sarah L Chamlin, Eric L Simpson, Lawrence F Eichenfield, Steven R Feldman, Dermatology and Therapy

Lectures

  • Atopic Dermatitis 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

Authored Content

  • Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJune 2020

Press Mentions

  • Rapid Improvement in Atopic Dermatitis with Topical PDE4 Inhibitor
    Rapid Improvement in Atopic Dermatitis with Topical PDE4 InhibitorMarch 20th, 2023
  • New Data Show Promising Results in the Treatment of Atopic Dermatitis on Hands and Feet
    New Data Show Promising Results in the Treatment of Atopic Dermatitis on Hands and FeetMarch 19th, 2023
  • Dupilumab Improves Hand, Foot Atopic Dermatitis in Phase 3 Study
    Dupilumab Improves Hand, Foot Atopic Dermatitis in Phase 3 StudyMarch 19th, 2023
  • Join now to see all

Grant Support

  • The Role Of The Skin Barrier In Atopic Dermatitis Development And PreventionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012

Professional Memberships

Hospital Affiliations